Correction to: BMC Gastroenterology (2022) 22:498 10.1186/s12876-022-02583-5
After publication of this article [1], the authors reported that the given and family names of most authors were incorrectly structured. The correct list of authors is: Cassandra Rayer, Maria Nachury, Arnaud Bourreille, Xavier Roblin, Laurent Peyrin-Biroulet, Stephanie Viennot, Mathurin Flamant, David Laharie, Bénédicte Caron, Marie Dewitte, Laurent Siproudhis, Mathurin Fumery and Guillaume Bouguen.
The original article [1] has been corrected.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Reference
- 1.Rayer C, Nachury M, Bourreille A, Roblin X, Peyrin-Biroulet L, Viennot S, Flamant M, Laharie D, Caron B, Dewitte M, Siproudhis L, Fumery M, Bouguen G. Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study. BMC Gastroenterol. 2022;22:498. doi: 10.1186/s12876-022-02583-5. [DOI] [PMC free article] [PubMed] [Google Scholar]